Results 41 to 50 of about 3,528 (147)

Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report

Vaccines, 2021
Real-life data on the performance of vaccines against SARS-CoV-2 are still limited. We here present the rates of detection and levels of antibodies specific for the SARS-CoV-2 spike protein RBD (receptor binding domain) elicited by four vaccines ...
Olivera Lijeskić, Ivana Klun, Marija Stamenov Djaković, Nenad Gligorić, Tijana Štajner, Jelena Srbljanović, Olgica Djurković-Djaković   +6 more
doaj   +1 more source

Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco

BMC Public Health, 2022
Background The Kingdom of Morocco approved BBIBP-CorV (Sinopharm) COVID-19 vaccine for emergency use on 22 January 2021 in a two-dose, three-to-four-week interval schedule.
Yaowen Zhang, Jihane Belayachi, Yunkai Yang, Qiang Fu, Lance Rodewald, Hongling Li, Bing Yan, Ying Wang, Yanna Shen, Qian Yang, Weiyun Mu, Rong Tang, Chen Su, Tianfang Xu, Majdouline Obtel, Abdelkader Mhayi, Rachid Razine, Redouane Abouqal, Yuntao Zhang, Xiaoming Yang   +19 more
doaj   +1 more source

Neutralizing immunity against SARS-CoV-2 Omicron BA.1 by infection and vaccination

iScience, 2022
Summary: The emergence of the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant has raised questions regarding resistance to neutralizing antibodies elicited by natural infection or immunization.
Li-Jun Duan, Wen-Guo Jiang, Zhuang-Ye Wang, Lin Yao, Ka-Li Zhu, Qing-Chuan Meng, Bao-Shan Wang, Li-Bo Li, Guo-Lin Wang, Mai-Juan Ma   +9 more
doaj   +1 more source

Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine

, 2022
We investigate whether the human gut microbiota and metabolic function correlate with the inactivated SARS-CoV-2 vaccine (BBIBP-CorV, CNBG) response. A total of 207 participants who receive the BBIBP-CorV vaccine at Days 0 and 28 are enrolled.
Tang, B
core   +2 more sources

PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals

Scientific Reports, 2023
The optimal booster vaccine schedule against COVID-19 is still being explored. The present study aimed at assessment of the immunogenicity and antibody persistency of inactivated-virus based vaccine, BBIP-CorV and protein-subunit based vaccines ...
Amitis Ramezani, Rahim Sorouri, Saiedeh Haji Maghsoudi, Sarah Dahmardeh, Delaram Doroud, Mona Sadat Larijani, Sana Eybpoosh, Ehsan Mostafavi, Alireza Olyaeemanesh, Mostafa Salehi-Vaziri, Anahita Bavand, Ghazaleh Zarghani, Ladan Moradi, Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Parisa Mashayekhi, Zahra Tahmasebi, Alireza Biglari   +17 more
doaj   +1 more source

Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population

Vaccines, 2022
Background: Knowledge about a vaccine’s side effects and efficacy is important to improving public vaccine acceptance. This study aimed to detect the safety and efficacy of vaccines among the Egyptian population.
Marwa O. Elgendy, Ahmed O. El-Gendy, Sarah Mahmoud, Tarek Yehia Mohammed, Mohamed E. A. Abdelrahim, Ahmed M. Sayed   +5 more
doaj   +1 more source

A study of Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine. Tang et al.

, 2022
We investigate whether the human gut microbiota and metabolic function correlate with the inactivated SARS-CoV-2 vaccine (BBIBP-CorV, CNBG) response. A total of 207 participants who receive the BBIBP-CorV vaccine at Days 0 and 28 are enrolled.
Tang, B (via Mendeley Data)
core   +3 more sources

Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave in Peru

Vaccines, 2023
We evaluated neutralizing antibody (NAbs) levels as a protective factor against vaccine breakthrough infection (VBI) in healthcare workers (HCWs) during the third COVID-19 wave in Peru.
Miguel Hueda-Zavaleta, Juan C. Gómez de la Torre, José Alonso Cáceres-DelAguila, Cecilia Muro-Rojo, Nathalia De La Cruz-Escurra, Cesar Copaja-Corzo, Carlos J. Aragón-Ayala, Vicente A. Benítes-Zapata   +7 more
doaj   +1 more source

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants

Genome Medicine, 2022
Background The emergence of SARS-CoV-2 Omicron subvariants has raised questions regarding resistance to immunity by natural infection or immunization.
Xue-Jun Wang, Lin Yao, Hong-Yun Zhang, Ka-Li Zhu, Jing Zhao, Bing-Dong Zhan, Yi-Ke Li, Xue-Juan He, Cong Huang, Zhuang-Ye Wang, Ming-Dong Jiang, Peng Yang, Yang Yang, Guo-Lin Wang, Sheng-Qi Wang, Er-Hei Dai, Hui-Xia Gao, Mai-Juan Ma   +17 more
doaj   +1 more source

Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination

Frontiers in Immunology, 2022
BackgroundBBIBP-CorV and CoronaVac inactivated COVID-19 vaccines are widely-used, World Health Organization-emergency-listed vaccines. Understanding antibody level changes over time after vaccination is important for booster dose policies.
Fuzhen Wang, Baoying Huang, Huakun Lv, Lizhong Feng, Weihong Ren, Xiaoqi Wang, Lin Tang, Qianqian Liu, Dan Wu, Hui Zheng, Zhijie An, Yao Deng, Li Zhao, Fei Ye, Wenling Wang, Hangjie Zhang, Shaoying Chang, Yuting Liao, Fengyang Chen, Lance E. Rodewald, George F. Gao, Zundong Yin, Wenjie Tan   +22 more
doaj   +1 more source